Biosimilar
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Effectiveness of Biosimilar Ranibizumab in the Management of Diabetic Macular Edema (NCT07663370) | Benha University | 2022-01-01 |
| HER2-directed Biosimilar in Breast Cancer: Real World ePRO (NCT05234021) | OnkoZentrum Zürich AG | 2021-12-14 |
| Multi-Centre, Observational Study on Safety of Bevacizumab Biosimilars in Clinical Practice Among Chinese Patients (NCT05009017) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-01-01 |
Track Biosimilar automatically
Every clearance here is in the API, with alerts when new ones post.